Fu Peng
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 8
-
- Circular RNAs in diseases 4
- Natural product bioactivities and synthesis 4
- Bioactive natural compounds 3
- Co-authors
- Cheng Yun Peng (31 shared papers)Lei Yu (3 shared papers)Hailin Tang (8 shared papers)Junren Chen (10 shared papers)Xiaofang Xie (10 shared papers)Jianping Chen (1 shared paper)Qingqing Liu (1 shared paper)Dan Li (5 shared papers)
In The Last Decade
Fu Peng
60 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 270
- Pharmacology 163
- Complementary and alternative medicine 101
- Biochemistry 66
- Molecular Biology 745
Countries citing papers authored by Fu Peng
This map shows the geographic impact of Fu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Peng more than expected).
Fields of papers citing papers by Fu Peng
This network shows the impact of papers produced by Fu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Peng. The network helps show where Fu Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 155 | |
| 2 | 2021 | 111 | |
| 3 | 2022 | 102 | |
| 4 | 2021 | 91 | |
| 5 | 2019 | 89 | |
| 6 | 2022 | 89 | |
| 7 | 2018 | 76 | |
| 8 | 2023 | 68 | |
| 9 | 2022 | 67 | |
| 10 | 2021 | 67 | |
| 11 | 2023 | 53 | |
| 12 | 2015 | 52 | |
| 13 | 2023 | 52 | |
| 14 | 2021 | 48 | |
| 15 | 2020 | 48 | |
| 16 | 2019 | 33 | |
| 17 | 2021 | 33 | |
| 18 | 2021 | 31 | |
| 19 | 2019 | 29 | |
| 20 | 2022 | 29 |
About Fu Peng
Fu Peng is a scholar working on Cancer Research, Molecular Biology, Pharmacology, Oncology and Complementary and alternative medicine, having authored 70 papers that have together received 1.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers), Essential Oils and Antimicrobial Activity (5 papers), Cancer Mechanisms and Therapy (4 papers), Cancer Cells and Metastasis (4 papers), Circular RNAs in diseases (4 papers), Natural product bioactivities and synthesis (4 papers) and Bioactive natural compounds (3 papers). The work is most often cited by research in Cancer Research (270 citations), Pharmacology (163 citations), Complementary and alternative medicine (101 citations), Biochemistry (66 citations) and Molecular Biology (745 citations). Fu Peng has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Cheng Yun Peng, Lei Yu, Hailin Tang, Junren Chen, Xiaofang Xie, Jianping Chen, Qingqing Liu, Dan Li, Yan Chen and Gangmin Li. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology, The American Journal of Chinese Medicine, Frontiers in Immunology and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.